BPH Global (ASX:BP8) Common Stock: A$81.63 Mil (As of Dec. 2025)


What is BPH Global Common Stock?

BPH Global ASX:BP8 +33.33% Common Stock is A$81.63 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

BPH Global's quarterly common stock increased from Dec. 2024 (A$78.97 Mil) to Jun. 2025 (A$80.20 Mil) and increased from Jun. 2025 (A$80.20 Mil) to Dec. 2025 (A$81.63 Mil).

BPH Global's annual common stock increased from Jun. 2023 (A$78.28 Mil) to Jun. 2024 (A$78.94 Mil) and increased from Jun. 2024 (A$78.94 Mil) to Jun. 2025 (A$80.20 Mil).

BPH Global Common Stock Historical Data

* Premium members only.

The historical data trend for BPH Global's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BPH Global Common Stock Chart

BPH Global Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.57 76.88 78.28 78.94 80.20

BPH Global Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.92 78.94 78.97 80.20 81.63

BPH Global Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$81.63 Mil mean?
BPH Global (ASX:BP8) has a Common Stock of A$81.63 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BPH Global and its competitors.
Is BPH Global's Common Stock too high?
BPH Global's current Common Stock is A$81.63 Mil.
How does BPH Global's Common Stock compare to ZTS and UTHR?
BPH Global's Common Stock of A$81.63 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BPH Global and its competitors. BPH Global's current Common Stock is A$81.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8) has a current Common Stock of A$81.63 Mil. The current Common Stock is A$81.63 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For BPH Global (ASX:BP8), the current Common Stock is A$81.63 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BPH Global Business Description

Other Exchanges USZ0:Germany
Address 96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.